Financials in USD. Standardized financial statements.
A compact view of how 4DMedical Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $5.85M | $3.05M | $718,581 | $1.05M | $216,978 | $1.23M | $695,000 | $789,259 | $1,925 | $350,890 |
| Revenue Growth? | +91.9% | +324.4% | -31.8% | +385.9% | -82.4% | +77.3% | -11.9% | +40900.5% | -99.5% | 0.0% |
| Cost of Revenue? | $464,426 | $236,717 | $25.00M | $773,683 | $91,853 | $9.37M | $4.42M | $3.80M | $2.93M | $28,618 |
| Gross Profit? | $5.39M | $2.81M | -$24.28M | $280,617 | $125,125 | -$8.13M | -$3.73M | -$3.01M | -$2.93M | $322,272 |
| Gross Margin? | +92.1% | +92.2% | -3378.6% | +26.6% | +57.7% | -660.0% | -536.3% | -382.0% | -152283.9% | +91.8% |
| Operating Expenses? | $34.61M | $49.42M | $20.29M | $22.48M | $13.82M | $7.83M | $3.29M | $2.16M | $1.75M | $1.12M |
| Operating Income? | -$29.22M | -$46.61M | -$30.65M | -$22.20M | -$13.69M | -$15.96M | -$7.02M | -$5.17M | -$4.68M | -$854,869 |
| EBITDA? | -$46.05M | -$31.86M | -$43.83M | -$35.25M | -$18.04M | -$14.19M | -$6.74M | -$5.01M | -$4.55M | -$838,886 |
| Income Before Tax | -$30.16M | -$35.93M | -$31.14M | -$24.55M | -$21.41M | -$22.79M | -$7.14M | -$4.53M | -$4.65M | -$796,268 |
| Income Tax Expense | $87,118 | $48,411 | $323,222 | $43,208 | $15,308 | -$817,961 | -$650,607 | -$592,794 | -$679,933 | $0 |
| Net Income? | -$30.07M | -$35.98M | -$31.46M | -$24.59M | -$21.42M | -$21.98M | -$6.49M | -$3.94M | -$3.97M | -$796,268 |
| EPS? | $-0.07 | $-0.11 | $-0.10 | $-0.08 | $-0.08 | $-0.08 | $-0.04 | $-0.03 | $-0.03 | $-32.77 |
| Diluted EPS? | $-0.14 | $-0.10 | $-0.10 | $-0.08 | $-0.08 | $-0.08 | $-0.04 | $-0.03 | $-0.03 | $-32.77 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality